Filing step-change
PHARMAID · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
Pharmaid's quarterly earnings report shows a notable improvement in its standard shift, driven by a significant acceleration in its gross margin.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 39.76 % | -29.85 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -29.85 % | -18 | ▼ |
Cite this
Source: Samhati filing step-change for PHARMAID (2026-09). Observation: Pharmaid's quarterly earnings report shows a notable improvement in its standard shift, driven by a significant acceleration in its gross margin. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/pharmaid/q/2026-09
Other periods